Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease (Q40395727)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 1994

edit

Language	Label	Description	Also known as
English	Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease	scientific article published on October 1994

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Abciximab (c7E3 Fab). A review of its pharmacology and therapeutic potential in ischaemic heart disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

main subject

pharmacology

1 reference

based on heuristic

inferred from title

author name string

D Faulds

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

E M Sorkin

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

publication date

1 October 1994

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

published in

Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

volume

48

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

page(s)

583-598

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

cites work

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombolysis in acute myocardial infarction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine prepa

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human platelet function in vivo with a monoclonal antibody. With observations on the newly dead as experimental subjects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of therapeutic blocking of Gp IIb/IIIa on platelet alpha-granular fibrinogen

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic lysis protects against the effects of platelet activation during coronary thrombolysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelets and thrombolytic therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein IIb/IIIa in patients undergoing elective coronary angioplasty

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Pharmacokinetics of Interferons

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous T

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7528131

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003495-199448040-00007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

Dimensions Publication ID

1032387399

0 references

PubMed publication ID

7528131

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7528131

retrieved

20 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40395727&oldid=2203656867"